OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,146,000 | -23.2% | 517,133 | -25.6% | 0.79% | -29.6% |
| Q2 2022 | $2,794,000 | -18.8% | 695,000 | 0.0% | 1.12% | -2.9% |
| Q1 2022 | $3,440,000 | -29.0% | 695,000 | 0.0% | 1.15% | -13.8% |
| Q4 2021 | $4,844,000 | -12.9% | 695,000 | +25.0% | 1.34% | -8.4% |
| Q3 2021 | $5,560,000 | +53.1% | 556,000 | +117.1% | 1.46% | +73.2% |
| Q2 2021 | $3,632,000 | -31.6% | 256,152 | -21.5% | 0.84% | -42.9% |
| Q1 2021 | $5,313,000 | -15.3% | 326,174 | +7.6% | 1.48% | -37.0% |
| Q4 2020 | $6,276,000 | – | 303,174 | – | 2.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |